Evolent Health, Inc.
Hedge Funds Holdings
Last updated:
Evolent Health, Inc.‘s stocks are currently a part of 207 hedge funds’ portfolios, which represents 99.6% of the total amount of its stocks outstanding. This makes up a total of 85.71M shares of Evolent Health, Inc.. Compared to the previous quarter, the number grew by 1.20% or 1.01M shares more. As for the holding position changes, 40.58% (84) of current hedge fund investors increased the number of shares held, 34.78% (72) of current holders sold a part of the shares held, and 11.11% (23) closed the holdings completely. 33 hedge funds are new holders of Evolent Health, Inc. stock in Q1 2022, it is 15.94% of total holders.
Hedge funds holding Evolent Health (Q2 2017 – Q1 2022)
| Q2 2017 | 166 |
|---|---|
| Q3 2017 | 164 |
| Q4 2017 | 155 |
| Q1 2018 | 151 |
| Q2 2018 | 178 |
| Q3 2018 | 187 |
| Q4 2018 | 184 |
| Q1 2019 | 189 |
| Q2 2019 | 183 |
| Q3 2019 | 170 |
| Q4 2019 | 164 |
| Q1 2020 | 148 |
| Q2 2020 | 132 |
| Q3 2020 | 149 |
| Q4 2020 | 154 |
| Q1 2021 | 163 |
| Q2 2021 | 174 |
| Q3 2021 | 206 |
| Q4 2021 | 202 |
| Q1 2022 | 207 |
Hedge funds changes in Evolent Health positions (Q2 2017 – Q1 2022)
| Q2 2017 | 49 | 64 | 42 | 14 | -3 |
|---|---|---|---|---|---|
| Q3 2017 | 33 | 77 | 31 | 35 | -12 |
| Q4 2017 | 37 | 73 | 27 | 45 | -27 |
| Q1 2018 | 23 | 57 | 39 | 26 | 6 |
| Q2 2018 | 50 | 56 | 48 | 20 | 4 |
| Q3 2018 | 34 | 75 | 50 | 25 | 3 |
| Q4 2018 | 33 | 79 | 48 | 36 | -12 |
| Q1 2019 | 39 | 71 | 49 | 33 | -3 |
| Q2 2019 | 33 | 84 | 34 | 36 | -4 |
| Q3 2019 | 18 | 81 | 45 | 29 | -3 |
| Q4 2019 | 26 | 54 | 57 | 29 | -2 |
| Q1 2020 | 22 | 54 | 49 | 36 | -13 |
| Q2 2020 | 21 | 46 | 42 | 36 | -13 |
| Q3 2020 | 40 | 37 | 53 | 22 | -3 |
| Q4 2020 | 28 | 46 | 51 | 24 | 5 |
| Q1 2021 | 30 | 49 | 63 | 18 | 3 |
| Q2 2021 | 33 | 55 | 56 | 21 | 9 |
| Q3 2021 | 45 | 50 | 78 | 13 | 20 |
| Q4 2021 | 36 | 72 | 62 | 39 | -7 |
| Q1 2022 | 33 | 84 | 72 | 23 | -5 |
Hedge funds changes in Evolent Health stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 3,929,000 | 2,623,000 |
|---|---|---|
| Q3 2017 | 6,880,000 | 2,095,000 |
| Q4 2017 | 1,277,000 | 920,000 |
| Q1 2018 | 1,487,000 | 1,402,000 |
| Q2 2018 | 5,420,000 | 285,000 |
| Q3 2018 | 2,342,000 | 2,805,000 |
| Q4 2018 | 2,495,000 | 820,000 |
| Q1 2019 | 5,279,000 | 3,557,000 |
| Q2 2019 | 6,014,000 | 1,748,000 |
| Q3 2019 | 12,116,000 | 2,616,000 |
| Q4 2019 | 6,312,000 | 6,994,000 |
| Q1 2020 | 1,871,000 | 1,262,000 |
| Q2 2020 | 1,799,000 | 1,768,000 |
| Q3 2020 | 5,885,000 | 2,542,000 |
| Q4 2020 | 3,156,000 | 3,854,000 |
| Q1 2021 | 5,505,000 | 2,399,000 |
| Q2 2021 | 5,048,000 | 2,566,000 |
| Q3 2021 | 62,013,000 | 13,851,000 |
| Q4 2021 | 15,237,000 | 3,742,000 |
| Q1 2022 | 9,863,000 | 6,966,000 |